Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma Patients [Phase 3]
Phase 3 trial evaluating mobilization of stem cells with plerixafor (AMD3100) in patients with Non-Hodgkin lymphoma has completed and posted…
-
CLINICAL_TRIALS trial_result · 2010-09-28Clinical Trial Update: Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma
This clinical trial update indicates that a study evaluating hematopoietic recovery after chemotherapy in Non-Hodgkin's Lymphoma has been te…
-
CLINICAL_TRIALS trial_result · 2010-09-22Clinical Trial Update: High Dose CHOP in Lymphoma [Phase 2]
A Phase 2 trial evaluating high-dose CHOP chemotherapy in patients with Non-Hodgkin's Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-09-13Clinical Trial Update: A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma [Phase 1, Phase 2]
Phase 1/2 dose-finding trial of AMG 531 for chemotherapy-induced thrombocytopenia in adults with lymphoma; the study completed and results w…
-
CLINICAL_TRIALS trial_result · 2010-08-30Clinical Trial Update: Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial comparing rituximab plus sargramostim versus rituximab alone in relapsed follicular B-cell lymphoma (a form of non-Hodgkin l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating a biological therapy after chemotherapy in patients with relapsed or refractory non-Hodgkin lymphoma has…
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: A Prospective Observational Study to Evaluate the Quality of Life and the Costs in a Real Life Setting in Patients Who Are Treated With 90Y-Zevalin
This completed prospective observational study evaluated quality of life and costs in real-world patients treated with 90Y-Zevalin (ibritumo…
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone [Phase 2]
Phase 2 trial of plerixafor (AMD3100) in multiple myeloma or non-Hodgkin lymphoma patients predicted to be unable to mobilize with G-CSF alo…
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating the use of PET/CT imaging to assess treatment response in Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 study update evaluating the reproducibility of the BodyFIX immobilization device in Hodgkin lymphoma and non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating high-dose busulfan and high-dose cyclophosphamide conditioning followed by donor bone marrow transplantation in p…
-
CLINICAL_TRIALS trial_result · 2010-08-02Clinical Trial Update: Comparison Of Rituximab Versus Tositumomab and Iodine I 131 Tositumomab (BEXXAR® Therapeutic Regimen) For Patients With Relapsed Follicular Non-Hodgkins Lymphoma [Phase 3]
A Phase 3 trial comparing Rituximab to Tositumomab with I-131 Tositumomab in relapsed follicular lymphoma has completed and posted results i…
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia [Phase 1, Phase 2]
Phase 1/2 trial evaluating donor natural killer cell infusion with Rituximab, Aldesleukin, and chemotherapy in relapsed non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2010-07-29Clinical Trial Update: The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD) [Phase 2]
A Phase 2 trial evaluated the effect of Rituximab on stem cell mobilization when used with AMD3100 (plerixafor) and G-CSF in relapsed or ref…
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: Multicenter Cross Sectional Study of Primary Intestine Lymphoma
A multicenter cross-sectional study on primary intestinal lymphoma (a form of Non-Hodgkin lymphoma) has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-27Clinical Trial Update: High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating high-dose chemotherapy with an allogeneic hematopoietic cell transplant for Non-Hodgkin lymphoma has com…
-
CLINICAL_TRIALS trial_result · 2010-07-22Clinical Trial Update: Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma [Phase 2]
The Phase 2 clinical study of SyB L-0501 in patients with indolent B-cell non-Hodgkin's lymphoma and mantle cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-14Clinical Trial Update: Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients [Phase 2]
Phase 2 trial evaluating stem cell mobilization using plerixafor in combination with chemotherapy and G-CSF in patients with multiple myelom…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin as 2nd Line Therapy for Non-Hodgkin's Lymphoma (NHL) [Phase 2]
Phase 2 clinical trial evaluating a combination of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin as second-line thera…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of BL22 immunotoxin in patients with refractory chronic lymphocytic leukemia, prolymphocytic leukemia, and non-Hodgkin lymphom…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Bleomycin in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating Bleomycin for Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]
This Phase 1 trial of gene therapy and chemotherapy in patients with advanced solid tumors and Non-Hodgkin lymphoma was terminated, with no …
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial evaluating cyclophosphamide with or without rituximab followed by peripheral stem cell transplantation in patients with recu…
-
CLINICAL_TRIALS trial_result · 2010-06-10Clinical Trial Update: Molecular Risk Assessment in Planning Treatment for Patients With Non-Hodgkin's Lymphoma [Phase 2]
This clinical trial update notes the completion of a Phase 2 study on using molecular risk assessment to guide treatment decisions for patie…
-
CLINICAL_TRIALS trial_result · 2010-05-20Clinical Trial Update: Phase I Study of the Proteosome Inhibitor CEP 18770 in Patients With Solid Tumours or Non-Hodgkin's Lymphomas [Phase 1]
A Phase I study of CEP-18770, a proteasome inhibitor, in patients with solid tumors and Non-Hodgkin lymphoma has been completed.